UnknownNot Applicable

ADJUNCTIVE EFFECT OF LIGHT EMITTING DIODE ON HAND GRIP STRENGTH IN BURN PATIENTS

Egypt60 participantsStarted 2022-02-25

Plain-language summary

This study will be done to evaluate effect of applying LED before hand exercise on hand grip strength. Sixty male patients with subacute partial thickness burn of hand will be randomly allocated into two equal groups of 30 patients. The following equipment and tools will be used Measurement equipments: * For total active motion of fingers (TAM): Goniometer. * For hand grip strength: Hand grip dynamometer. Therapeutic equipment: Light emitting diode therapy (LED) device.

Who can participate

Age range

20 Years – 35 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: The subject selection will be according to the following criteria: * Burn caused by thermal injury (flame or scald) with involvement of the wrist and hand and other parts of the body not including shoulder and elbow. * Age range between 20-35 years. * Male gender. * Subacute Partial-thickness burn " From 3rd day of burn". * Recent discharge of in patient acute care, spontaneous healing. * All patients enrolled to the study will have their informed consent. Exclusion Criteria: The potential participants will be excluded if they meet one of the following criteria: * Cardiac diseases. * Perception of persistent respiratory problem related to a previous inhalation injury * Signs of burn infection (i.e., unclear fluid oozing from the wound, increased pain, expanded redness and swelling) * Exposed tendons. * Nerve, muscle injury. * Scar contracture of hand. * Cognitive disorders. * Presence of fractures. * Patients who suffer from skin diseases, diabetes, varicose veins, and peripheral vascular diseases. * Patients with life threatening disorders as renal failure, myocardial infarction or other similar diseases will be excluded from the study.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Changes in Total active ROM from baseline to 6 weeks posttreatment

Timeframe: baseline and 6 weeks posttreatment

Changes in hand grip strength from baseline to 6 weeks posttreatment

Timeframe: baseline and 6 weeks posttreatment

Trial details

NCT IDNCT05212441

SponsorOctober 6 University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-07-01

View on ClinicalTrials.gov More Burns trials